Nasopharyngeal Carcinoma: all 824 studies
Page 3 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- BGT007 Cell Treatment of Nasopharyngeal CarcinomaRecruitingNCT05616468Early Phase 1
- Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal CarcinomaRecruitingNCT05587543Early Phase 1
- Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPCRecruitingNCT05549466Phase 2
- Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaRecruitingNCT05527470Phase 3
- Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International GuidelinesNot yet recruitingNCT05519956Phase 3
- tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)RecruitingNCT05517135
- Radiotherapy Combined With Endostatin and Capecitabine for NPCRecruitingNCT05514275Phase 2
- Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05508347Phase 2
- Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line TreatmentNot yet recruitingNCT05484375Phase 2
- Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal CarcinomaRecruitingNCT05448885Phase 2
- Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma ScreeningRecruitingNCT05447169
- A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPCNot yet recruitingNCT05433597Phase 2/3
- A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT05432219Not applicable
- Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05431764Phase 2
- Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter StudyNot yet recruitingNCT05417139Phase 2
- Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasRecruitingNCT05415098Phase 1
- Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.RecruitingNCT05397769Phase 2
- Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal CarcinomaRecruitingNCT05385926Phase 2
- Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal CarcinomaRecruitingNCT05352321Not applicable
- Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPCRecruitingNCT05350891Phase 2
- Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaRecruitingNCT05342792Phase 3
- PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT05341193Phase 1/2
- Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III TrialRecruitingNCT05340491Phase 3
- Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic ImagesRecruitingNCT05202626
- Ovarian Function of Nasopharyngeal Carcinoma Women SurvivorsNot yet recruitingNCT05183724
- Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal CarcinomaRecruitingNCT05177237Phase 2
- Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05147844Phase 2
- RAPA-201 Therapy of Solid TumorsRecruitingNCT05144698Phase 1/2
- Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05128201Phase 2
- Immune Score Based Radiomics in Nasopharyngeal CarcinomaRecruitingNCT05126160
- Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05097209Phase 2
- ICCRT vs. CRT for Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05062005Phase 3
- Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal CarcinomaRecruitingNCT05011227Phase 2
- Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line ChemotherapyRecruitingNCT04978012Phase 2
- Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT04944914Phase 3
- Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal CarcinomaRecruitingNCT04898374Phase 3
- An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPCNot yet recruitingNCT04890522Phase 2/3
- Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal CarcinomaNot yet recruitingNCT04870905Phase 2
- The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPCRecruitingNCT04830267Phase 2
- 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT04813705Phase 2
- Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal CarcinomaRecruitingNCT04782765Phase 2
- Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT04778956Phase 3
- The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingNCT04769076Phase 2
- Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal CarcinomaNot yet recruitingNCT04766359Phase 3
- Umbrella Biomarker-Guided Therapy in NPCNot yet recruitingNCT04605562Phase 2
- Magnifying NBI for Occult NPCRecruitingNCT04593186Not applicable
- Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPCRecruitingNCT04557020Phase 3
- To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal CarcinomaRecruitingNCT04547673
- Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPCRecruitingNCT04544969
- A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiationNot yet recruitingNCT04534855Phase 2
- Individualized Carbon-Ion Radiotherapy for Patients With Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT04533620Phase 2
- Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT04522050Phase 1
- Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal CarcinomaRecruitingNCT04453826Phase 3
- Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal CarcinomaRecruitingNCT04453813Phase 3
- Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal CarcinomaRecruitingNCT04448522Phase 3
- Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal CarcinomaNot yet recruitingNCT04447326Phase 2
- Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal CarcinomaRecruitingNCT04437329Phase 3
- Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With MalnutritionRecruitingNCT04436965Phase 3
- Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal CarcinomaRecruitingNCT04425265Not applicable
- Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT04414566Phase 3
- Toripalimab for Local-regional Recurrent Nasopharyngeal CarcinomaRecruitingNCT04376866Phase 3
- SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT04351282Not applicable
- Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsRecruitingNCT04340024
- Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT04221516Phase 2
- Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRTNot yet recruitingNCT04215510Phase 3
- Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal CarcinomaRecruitingNCT04143984Phase 2
- Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal CarcinomaRecruitingNCT04136886Phase 3
- Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan CityRecruitingNCT04085900
- Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal CarcinomaRecruitingNCT03919552Phase 3
- Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal CarcinomaRecruitingNCT03908372Phase 2/3
- PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma PatientsRecruitingNCT03907826Phase 3
- PET/MR in Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT03657017Not applicable
- The Children and Adolescents Nasopharyngeal Carcinoma Survivor StudyNot yet recruitingNCT03637634
- Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal CarcinomaNot yet recruitingNCT03539250Not applicable
- CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and RadiotherapyNot yet recruitingNCT03529279Phase 3
- Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPCNot yet recruitingNCT03503136Phase 3
- Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma PatientsRecruitingNCT03353467Not applicable
- Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic LesionsRecruitingNCT03129412Phase 2
- Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerRecruitingNCT03010150
- Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal CarcinomaRecruitingNCT02610010Phase 3
- Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"RecruitingNCT01365169Not applicable
- Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPCTerminatedNCT05166577Phase 1Results posted
- Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal CancerTerminatedNCT04458909Phase 3Results posted
- Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)CompletedNCT03924986Phase 3Results posted
- Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)TerminatedNCT03769467Phase 1/2Results posted
- Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)TerminatedNCT03682055Phase 1/2Results posted
- Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabCompletedNCT03674567Phase 1/2Results posted
- SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.CompletedNCT03558191Phase 2Results posted
- Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)CompletedNCT03267498Phase 2Results posted
- Avelumab for Recurrent/Metastatic Nasopharyngeal CancerTerminatedNCT02875613Phase 2Results posted
- BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck CancerTerminatedNCT02706691Phase 2Results posted
- Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)CompletedNCT02611960Phase 3Results posted
- Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaCompletedNCT02605967Phase 2Results posted
- NBI to Detect Post-RT Mucosal Residual NPCCompletedNCT02584790Not applicableResults posted
- A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsCompletedNCT02578641Phase 3Results posted
- Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by SurgeryCompletedNCT02538510Phase 1/2Results posted
- Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal CancerCompletedNCT02339558Phase 2Results posted
- Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)Active, not recruitingNCT02287311Phase 1Results posted
- Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal CarcinomaCompletedNCT02269943Phase 2Results posted
- Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal CarcinomaTerminatedNCT02137096Phase 3Results posted